Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Pharmacology

Background:

• Therapeutic efficacy is often limited by solubility, administration route, and physiological barriers.
• Effective drug delivery systems are crucial for pharmaceutical advancement and drug bioavailability.
• Lipid nanoparticles (LNPs) have emerged as promising carriers for various therapeutics and vaccines.

Purpose of the Study:

• To review different types of lipid nanoparticles (LNPs) used in vaccine development.
• To discuss the clinical applications of messenger RNA (mRNA) delivered via LNPs.
• To explore recent trends in LNP-based vaccine research.

Main Methods:

• Literature review of lipid nanoparticle formulations for drug and vaccine delivery.
• Analysis of clinical trial data and research trends for LNP-based therapeutics.
• Discussion of advantages and applications of various LNP types.

Main Results:

• Various lipid-based nanoparticles (liposomes, SLNs, nanostructured LNPs) are utilized for vaccine delivery.
• LNPs demonstrate significant potential for delivering messenger RNA (mRNA) therapeutics.
• Ongoing research focuses on optimizing LNP formulations for enhanced vaccine efficacy and therapeutic delivery.

Conclusions:

• Lipid nanoparticles offer versatile platforms for developing advanced vaccines and mRNA therapeutics.
• The development of stable and effective LNP delivery systems is key to their clinical success.
• Continued research into LNP technology promises to expand their therapeutic applications.